According to filings with the U.S. Securities and Exchange Commission, Ultimaxx Health is raising $10,000,000.00 in new funding. Sources indicate that as part of senior management Executive, Leonard Lomax played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Ultimaxx Health
At Ultimaxx Health we have made it our mission to develop innovative solutions to pressing public health problems and Natural products that will improve the general health and well being of consumers. Our initial US Patented product is a safe, effective, clinically tested non-narcotic OTC pain relief alternative (tablet form), marketed under the trade name LEVARE (la-var-ay). LEVARE was developed to help mitigate the epidemic of prescription narcotic painkiller abuse in the U.S. The U.S. comprises 5% of the worlds population and consumes 80% of its prescription narcotics. Because of this excessive consumption, the U.S. is now in the midst of a serious epidemic of prescription narcotic misuse, abuse and overdoses. Prescription narcotics are now involved in more overdose deaths than heroin and cocaine combined.

To learn more about Ultimaxx Health, visit http://www.ultimaxxhealth.com/

Contact:
Leonard Lomax, Executive
877-300-3424
https://www.linkedin.com/in/lenny-lomax-m-d-6a1233/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.